Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in

Stefano Thellung1, Elena Gatta2, Francesca Pellistri2

  • 1Laboratory of Pharmacology, Department of Internal Medicine, and Center of Excellence for Biomedical Research (CEBR), University of Genova, 16132, Genoa, Italy.

Insights

Amyloidogenic prion protein fragments trigger neurotoxicity by disrupting calcium (Ca++) homeostasis. Glia activation amplifies this damage through nitric oxide and NADPH oxidase, exacerbating neurodegeneration in CNS disorders.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Glia over-stimulation and amyloid deposition are implicated in neurodegenerative disorders.
  • Prion protein (PrP)90-231, an amyloidogenic fragment, contributes to central nervous system pathology.

Purpose of the Study:

  • To investigate the molecular mechanisms of microglia-dependent neurotoxicity induced by PrP90-231.
  • To elucidate the role of calcium homeostasis disruption and glia activation in PrP90-231-mediated neurotoxicity.

Main Methods:

  • Co-culture of cerebellar granule neurons and glia.
  • Treatment with PrP90-231 and various pharmacological inhibitors (NMDA receptor antagonists, iNOS inhibitors, NADPH oxidase inhibitors).
  • Measurement of intracellular calcium ([Ca++]i) levels and assessment of neurotoxicity.

Main Results:

  • PrP90-231 neurotoxicity is enhanced by microglia, leading to rapid neuronal [Ca++]i increase.
  • In co-cultures, PrP90-231 activates inducible nitric oxide synthase (iNOS) and NADPH oxidase in glia, contributing to sustained [Ca++]i elevation and neurotoxicity.
  • In pure neuronal cultures, PrP90-231-induced neurotoxicity is primarily mediated by NMDA receptor activation.

Conclusions:

  • Amyloidogenic peptides like PrP90-231 induce neurotoxicity through direct neuronal interaction and glia activation.
  • Disruption of calcium homeostasis is a key mechanism, involving both excitotoxic pathways (NMDA receptors) and reactive species from activated glia.
  • Targeting glia-mediated pathways alongside excitotoxicity may offer therapeutic strategies for prion-related neurodegenerative diseases.